Journal article
Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial.
- Abstract:
-
BACKGROUND: Limited treatment data are available for hepatitis C virus (HCV) in sub-Saharan Africa, especially for genotype 4. Our objective was to establish the safety and efficacy of ledipasvir-sofosbuvir for chronic HCV genotype 1 or 4 infection in adults in Rwanda.
METHODS: We did a single-arm trial to evaluate the safety and efficacy of ledipasvir-sofosbuvir in Rwandan adults with chronic HCV infection at a single study site (Rwanda Military H...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Publisher copy:
- 10.1016/s2468-1253(18)30382-0
Authors
- Publisher:
- Elsevier
- Journal:
- Lancet Gastroenterology and Hepatology More from this journal
- Volume:
- 4
- Issue:
- 2
- Pages:
- 119-126
- Publication date:
- 2019-02-01
- Acceptance date:
- 2018-11-01
- DOI:
- ISSN:
-
2468-1253
- Pmid:
-
30552056
- Language:
-
English
- Pubs id:
-
pubs:954637
- UUID:
-
uuid:8ac53e52-c6c5-4a78-98a7-0128fb2c2530
- Local pid:
-
pubs:954637
- Source identifiers:
-
954637
- Deposit date:
-
2019-08-25
- ARK identifier:
Terms of use
- Copyright holder:
- Elsevier
- Copyright date:
- 2019
- Notes:
- © 2018 Elsevier Ltd. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record